Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTelix Pharmaceuticals Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2026 | 1 | $0.05 | $0.05 | $0.05 |
| Q1 2027 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2027 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2027 | 1 | $0.13 | $0.13 | $0.13 |
| Q4 2027 | 1 | $0.13 | $0.13 | $0.13 |
| Q1 2028 | 1 | $0.13 | $0.13 | $0.13 |
| Q2 2028 | 1 | $0.19 | $0.20 | $0.19 |
| Q3 2028 | 1 | $0.05 | $0.05 | $0.05 |
| Q4 2028 | 1 | $0.06 | $0.07 | $0.07 |
| Q1 2029 | 1 | $0.06 | $0.07 | $0.07 |
| Q2 2029 | 1 | $0.13 | $0.13 | $0.13 |
| Q3 2029 | 1 | $0.22 | $0.22 | $0.22 |
| Q4 2029 | 1 | $0.41 | $0.41 | $0.41 |
| Q1 2030 | 1 | $0.41 | $0.41 | $0.41 |
Telix Pharmaceuticals Ltd. Earnings Date And Information
Telix Pharmaceuticals Ltd. last posted its earnings results on Thursday, February 19th, 2026. The company reported $-0.0116 earnings per share for the quarter, missing analysts' consensus estimates of $0.03277 by $0.04437. The company had revenue of 620.44 M for the quarter and had revenue of 1.21 B for the year. Telix Pharmaceuticals Ltd. has generated $0 earnings per share over the last year ($-0.0316 diluted earnings per share) and currently has a price-to-earnings ratio of -474.56. Telix Pharmaceuticals Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Telix Pharmaceuticals Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 2025 | N/A | -$0.02 | N/A | $2.46 M | $620.44 M |
| 06/30/2025 | Q2 2025 | N/A | -$0.01 | N/A | $2.94 M | $593.11 M |
| 02/24/2025 | Q4 2024 | N/A | $0.12 | N/A | $3.05 M | $594.24 M |
| 06/28/2024 | Q2 2024 | N/A | $0.03 | N/A | N/A | $188.96 M |
| 12/30/2023 | Q4 2023 | N/A | $0.06 | N/A | N/A | $281.71 M |
| 06/29/2023 | Q2 2023 | $0.04 | -$0.05 | -0.08 | N/A | $220.83 M |
| 12/30/2022 | Q4 2022 | -$0.05 | -$0.10 | -0.05 | N/A | $136.05 M |
| 06/29/2022 | Q2 2022 | -$0.08 | -$0.23 | -0.15 | N/A | $24.05 M |
| 12/30/2021 | Q4 2021 | -$0.05 | -$0.17 | -0.12 | N/A | $4.69 M |
| 06/29/2021 | Q2 2021 | N/A | -$0.12 | N/A | N/A | $2.91 M |
| 12/30/2020 | Q4 2020 | N/A | -$0.10 | N/A | N/A | $3.61 M |
| 06/29/2020 | Q2 2020 | N/A | -$0.07 | N/A | N/A | $1.61 M |
| 12/30/2019 | Q4 2019 | N/A | -$0.07 | N/A | N/A | $1.67 M |
| 06/29/2019 | Q2 2019 | N/A | -$0.05 | N/A | N/A | $1.82 M |
| 12/31/2018 | Q4 2018 | N/A | -$0.04 | N/A | N/A | $195.00 K |
| 06/30/2018 | Q2 2018 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/31/2017 | Q4 2017 | N/A | -$0.02 | N/A | N/A | $48.79 K |
| 06/30/2017 | Q2 2017 | N/A | -$0.02 | N/A | N/A | $0 |
| 01/30/2017 | Q4 2016 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2016 | Q2 2016 | N/A | $0.01 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Telix Pharmaceuticals Ltd. Earnings: FAQ's
The conference call for Telix Pharmaceuticals Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Telix Pharmaceuticals Ltd.'s latest earnings report can be read online.
Telix Pharmaceuticals Ltd. (:TLX) has a recorded annual revenue of $1.21 B.
Telix Pharmaceuticals Ltd. (:TLX) has a recorded net income of $-10,685,154.Telix Pharmaceuticals Ltd. has generated $-0.0316 earnings per share over the last four quarters.
Telix Pharmaceuticals Ltd. (:TLX) has a price-to-earnings ratio of -474.56 and price/earnings-to-growth ratio is 3.91.